Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Ideaya Biosciences, Inc. (IDYA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 72,130,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   IDEAYA Biosciences is a synthetic lethality-focused precision medicine oncology company engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Co.'s primary synthetic lethality product candidate is IDE397, a clinical-stage methionine adenosyltransferase 2a inhibitor for patients with solid tumors having methylthioadenosine phosphorylase deletions. Co. is enrolling patients into a Phase 1 clinical trial designated as IDE397-001 to evaluate IDE397. Co. is targeting poly (ADP-ribose) glycohydrolase for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 101,372 268,000 311,470 311,470
Total Sell Value $4,587,595 $10,832,803 $11,979,134 $11,979,134
Total People Sold 2 3 4 4
Total Sell Transactions 3 11 26 26
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 129
  Page 2 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Throne Jason Chief Legal Officer   •       •      –    2023-09-01 4 AS $30.03 $63,063 D/D (2,100) 0     -
   Throne Jason Chief Legal Officer   •       •      –    2023-09-01 4 OE $12.86 $27,006 D/D 2,100 2,100     -
   Ruiz Briseno Andres See Remarks   •       •      –    2023-09-01 4 AS $30.01 $60,016 D/D (2,000) 32,531     -
   Stone Paul A. Chief Financial Officer   •       •      –    2023-08-29 4 AS $28.87 $144,352 D/D (5,000) 9,303     -
   Stone Paul A. Chief Financial Officer   •       •      –    2023-08-21 4 AS $26.40 $25,819 D/D (978) 14,303     -
   Stone Paul A. Chief Financial Officer   •       •      –    2023-08-18 4 AS $26.38 $100,820 D/D (3,822) 15,281     -
   Stone Paul A. Chief Financial Officer   •       •      –    2023-08-16 4 AS $26.40 $5,285 D/D (200) 19,103     -
   Throne Jason Chief Legal Officer   •       •      –    2023-08-09 4 AS $25.09 $125,430 D/D (5,000) 0     -
   Throne Jason Chief Legal Officer   •       •      –    2023-08-09 4 OE $13.34 $66,700 D/D 5,000 5,000     -
   Stone Paul A. Chief Financial Officer   •       •      –    2023-08-09 4 AS $25.05 $62,613 D/D (2,500) 19,303     -
   Throne Jason Chief Legal Officer   •       •      –    2023-07-10 4 AS $23.00 $218,178 D/D (9,485) 0     -
   Throne Jason Chief Legal Officer   •       •      –    2023-07-10 4 OE $7.01 $95,740 D/D 9,485 9,485     -
   Ruiz Briseno Andres See RemarksOfficer   •       –      –    2023-07-01 3 IO $0.00 $0 D/D 0 34,531     -
   Throne Jason Chief Legal Officer   •       •      –    2023-06-01 4 AS $23.02 $81,792 D/D (3,553) 0     -
   Throne Jason Chief Legal Officer   •       •      –    2023-06-01 4 OE $7.01 $24,907 D/D 3,553 3,553     -
   Throne Jason Chief Legal Officer   •       •      –    2023-05-31 4 AS $23.00 $9,938 D/D (432) 0     -
   Throne Jason Chief Legal Officer   •       •      –    2023-05-31 4 OE $7.01 $3,028 D/D 432 432     -
   Throne Jason Chief Legal Officer   •       •      –    2023-05-22 4 AS $23.00 $11,500 D/D (500) 0     -
   Throne Jason Chief Legal Officer   •       •      –    2023-05-22 4 OE $7.01 $3,505 D/D 500 500     -
   Stone Paul A. Chief Financial Officer   •       •      –    2023-04-13 4 OE $4.62 $36,960 D/D 8,000 21,803     -
   Hata Yujiro S President and CEO   •       •      –    2023-04-12 4 OE $4.31 $50,000 D/D 11,601 677,887     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-10-04 4 AS $25.85 $39,545 D/D (1,500) 78,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-10-04 4 OE $11.08 $16,620 D/D 1,500 80,289     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-09-08 4 AS $27.41 $312,093 D/D (11,384) 78,789     -
   Dillon Michael P. SVP, Chief Scientific Officer   •       –      –    2021-09-08 4 OE $4.31 $78,264 D/D 11,384 90,173     -

  129 Records found
  1  2  3  4  5  6   
  Page 2 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed